Parenteral Nutrition Market

Parenteral Nutrition Market Analysis By Nutrient Type (Carbohydrate-based Parenteral Nutrition Products, Parenteral Lipid Emulsion, Parenteral Nutrition Trace Elements) & By Region - Global Market Insights 2022 to 2032

Analysis of Parenteral Nutrition market covering 30+ countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Parenteral Nutrition Market Outlook (2022-2032)

The market for parenteral nutrition accrued significant gains, being valued at over US$ 6 Billion as of 2021.

The industry is expected to reach US$ 7 Billion by 2022-end, experiencing year on year increase of 16% compared to 2021. From 2022-2032, the industry is forecast to increase 2x to reach US$ 14 Billion.

Report Attributes

Details

Market Value for 2021

US$ 6 Billion

Anticipated Market Value for 2022

US$ 7 Billion

Forecasted Market Value for 2032

US$ 14 Billion

Global Growth Rate (2022-2032)

7% CAGR

Market Share of North America

42%

Value CAGR of Asia-Pacific

8%

Market Share of Single Dose Amino Acids

31%

Key Companies Profiled

  • Allergan Plc.
  • Baxter International
  • Vifor Pharma Group
  • Grifols S.A
  • Otsuka Pharmaceutical Co. Ltd.
  • Fresenius Kabi
  • B. Braun Melsungen AG
  • Pfizer Inc.
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Actavis Inc.

Parenteral Nutrition Demand Analysis 2015-2021 vs. Future Market Outlook 2022-2032

According to Fact.MR- a market research and competitive intelligence provider- parenteral nutrition products experienced a significant uptick in sales, flourishing at a CAGR of 6.4% from 2015 to 2021.

Rising demand for enhancing nutrition intake amongst immunocompromised patients due to the onset of chronic or infectious ailments has led to this high uptake.

During the COVID-19 pandemic, prospects further elevated, as healthcare providers relied on parenteral administration of vital body fluids and nutrients. Given the highly inflammatory nature of the disease, patients were rendered unable to consume nutrients orally, prompting parental nutrients administration. Moreover, it helped caretakers avoid contracting the infection themselves.

As the world population continue to expand, nutritional requirements are expected to surge manifold, especially across the low and middle-income countries.

Government initiatives to curb the incidence of malnutrition across these regions is opening new growth frontiers for parenteral nutrition products. As per this report, the market is forecast to experience a CAGR of 7% across the 2022-2032 assessment period.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Prominent Drivers Influencing Parenteral Nutrition Industry Expansion

Rising Prevalence of Chronic, Non-Communicable Diseases to Augment Growth

Non-communicable diseases (NCDs) lead to 41 million fatalities each year, equivalent to 71% of deaths globally, according to the World Health Organization. Each year, more than 15 million people die from an NCD between the ages of 30 and 69 years, and 85% of these premature deaths occur across low and middle-income countries.

Most of these fatalities arise out of lack of adequate minerals, vitamins or nutrients. Malnutrition is a serious problem plaguing both the developing as well as developed worlds. Currently, nearly 2 billion adults are overweight or obese, while 462 million are underweight.

Attributed to these disturbing trends, healthcare facilities worldwide are emphasizing on the importance of balancing nutritional intake, with active support from government and non-governmental agencies. This is consequently widening prospects for parenteral nutritional products. These products are extensively used to assist in nutritional intake of patients with severe illnesses.

High Incidence of Premature Births to Accelerate Parenteral Nutrition Uptake

The scope for parenteral nutrition has been further enhanced in the light of increasing numbers of premature births across multiple regions. It is documented that every year, around 15 million babies are born preterm- before the completion of the 37-week gestation period. Across 184 countries, this rate ranges from 5% to 18%.

Most premature babies suffer from low weight and undeveloped immunity, which puts them at risk. In addition, individuals and healthcare authorities are extensively focusing on limiting mortality due to early birth, thereby driving the use of parenteral lipid emulsions. 

Healthcare infrastructure across the most critical areas are being extensively revamped to accommodate the growing nutritional intake requirements of pre-term infants. This has considerably broadened growth prospects for parenteral nutrition products.

Region-wise Analysis

What are the Growth Prospects for the North American Market?

Increasing Prevalence of Nutritional Deficiency to Augment Adoption

According to Fact.MR, parenteral nutrition revenue is likely to be the largest across North America, expected to gather a market share worth 42% in 2022. Growth is majorly attributed to the increasing prevalence of nutritional inadequacy amongst both adults and children in recent years.

According to Johns Hopkins Medicine, across the United States, a significant proportion of children suffer from malnutrition due to dietary imbalances than due to nutritional deficiencies. About 1% of children across the U.S suffer from chronic malnutrition. Iron deficiency comprises most of the malnutrition cases across the country.

Estimates by the World Health Organization suggest that one in six women (16%) are iron deficient, especially during pregnancy, with the incidence higher among non-Hispanic blacks and Hispanics. Hence, a lot of patients are opting for parenteral nutritional products and services throughout the continent.

How do Growth Prospects Appear across the Asia-Pacific Region?

A Large Population Base and the Consequent Nutritional Requirement Bolstering Prospects

Sales of parenteral nutritional products are expected to grow the fastest across the Asia-Pacific. The presence of a large population base and the consequent rise in cases of inadequate nutritional intake- particularly across the developing world- has heightened growth prospects throughout the region.

Countries such as India represent the bulk of all growth opportunities in the long-run. It is reported that every day, more than 6,000 children below the age of 5 succumb to malnutrition in the country. Most of them are a result of lack of vitamin A, iron iodine, zinc and folic acid. About 57% of preschoolers and their mothers have sub-clinical Vitamin A deficiency.

Likewise, in China, mineral insufficiency comprises the highest form of malnutrition among adults, at around 99.97%, followed by vitamin deficiency (98.8%), overweight & obesity (39.58%) and underweight (~4%). Hence, governments are promoting extensive nutritional intake campaigns, elevating growth prospects. Fact.MR expects the Asia-Pacific market to proliferate at a CAGR of 8% through 2032.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Category-wise Insights

Which Parenteral Nutrient Type is forecast to Remain Dominant?

Single Dose Amino Acid Parenteral Nutrition Solutions to Remain Prominent

By nutrient type, sales of single dose amino acid parenteral nutrition solutions are expected to remain dominant, with an anticipated market share worth 31% in 2022 and beyond. This is attributed to increased usage of amino acid solutions.

Newly procured amino acids possess fewer side effects, thereby enhancing patient benefits. A combination of different amino acid grades have proven to enhance overall biological functioning of the patient. Hence, there is high reliance on this product.

Prospects for Parenteral Lipid Emulsions are expected to Heighten Significantly

Besides single dose amino acids, lipid emulsions are likely to enjoy rapid growth, expanding at a CAGR of 6.7% from 2022 to 2032. Growth is attributed to development of hybrid parenteral lipid emulsions from multiple sources to enhance patient health.

These formulations are manufactured through a combination of fish oil and olive oil. Moreover, the COVID-19 pandemic has prompted healthcare providers to offer parenteral nutrition over enteral approaches, with lipid emulsions proving to be the most convenient option.

Competitive Landscape

Prominent parenteral nutrition products manufacturers are striving to continuously improve their product offerings. They do so by introducing new product lines, consolidating their presence through collaborations and acquiring some small to medium-scale providers among others. Some key developments are as follows:

  • In January 2020, Fresenius Kabi completed its clinical trial for SmofKabiven- a new range of lipid emulsions. The product is manufactured from multiple oils, including fish, soybean & olive oils and medium-chain triglycerides.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Key Segments Covered in the Parenteral Nutrition Research Report

  • By Nutrient Type :

    • Carbohydrate-based Parenteral Nutrition Products
    • Parenteral Lipid Emulsion
    • Single Dose Amino Acid Parenteral Nutrition Solution
    • Parenteral Nutrition Trace Elements
    • Parenteral Vitamins & Minerals
  • By Region

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Parenteral Nutrition Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points 

    4.1. Global Parenteral Nutrition Market (US$ Mn)

    4.2. Parenteral Nutrition Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis 

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact 

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Parenteral Nutrition Market Growth

        4.5.3. Parenteral Nutrition Adoption Rate, by Country

    4.6. Market Dynamics 

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Parenteral Nutrition Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Parenteral Nutrition Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Parenteral Nutrition Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Parenteral Nutrition Market Analysis 2015-2021 and Forecast 2022-2032, By Nutrient Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Nutrient Type, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Nutrient Type, 2022-2032

        8.3.1. Carbohydrates

        8.3.2. Parenteral Lipid Emulsion

        8.3.3. Single Dose Amino Acid Solution

        8.3.4. Trace Elements

        8.3.5. Vitamins & Minerals

    8.4. Market Attractiveness Analysis By Nutrient Type

9. Global Parenteral Nutrition Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific 

        9.3.5. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Parenteral Nutrition Market Analysis 2015-2021 and Forecast 2022-2032

    10.1. Introduction

    10.2. Pricing Analysis

    10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        10.4.1. By Country

            10.4.1.1. U.S.

            10.4.1.2. Canada

        10.4.2. By Nutrient Type

    10.5. Market Attractiveness Analysis

        10.5.1. By Country

        10.5.2. By Nutrient Type

11. Latin America Parenteral Nutrition Market Analysis 2015-2021 and Forecast 2022-2032

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        11.4.1. By Country

            11.4.1.1. Brazil

            11.4.1.2. Mexico

            11.4.1.3. Rest of Latin America

        11.4.2. By Nutrient Type

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Nutrient Type

12. Europe Parenteral Nutrition Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. Germany

            12.4.1.2. France

            12.4.1.3. U.K.

            12.4.1.4. Italy

            12.4.1.5. Benelux

            12.4.1.6. Nordic Countries

            12.4.1.7. Rest of Europe

        12.4.2. By Nutrient Type

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Nutrient Type

13. Asia Pacific Parenteral Nutrition Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. China

            13.4.1.2. Japan

            13.4.1.3. South Korea

            13.4.1.4. Rest of Asia Paific

        13.4.2. By Nutrient Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Nutrient Type

14. Middle East and Africa Parenteral Nutrition Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. GCC Countries

            14.4.1.2. South Africa

            14.4.1.3. Turkey

            14.4.1.4. Rest of Middle East and Africa

        14.4.2. By Nutrient Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Nutrient Type

15. Key Countries Parenteral Nutrition Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

        15.1.1. Market Value Proportion Analysis, By Key Countries

        15.1.2. Global Vs. Country Growth Comparison

    15.2. US Parenteral Nutrition Market Analysis

        15.2.1. Value Proportion Analysis by Market Taxonomy

        15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.2.2.1. By Nutrient Type

    15.3. Canada Parenteral Nutrition Market Analysis

        15.3.1. Value Proportion Analysis by Market Taxonomy

        15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.3.2.1. By Nutrient Type

    15.4. Mexico Parenteral Nutrition Market Analysis

        15.4.1. Value Proportion Analysis by Market Taxonomy

        15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.4.2.1. By Nutrient Type

    15.5. Brazil Parenteral Nutrition Market Analysis

        15.5.1. Value Proportion Analysis by Market Taxonomy

        15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.5.2.1. By Nutrient Type

    15.6. Germany Parenteral Nutrition Market Analysis

        15.6.1. Value Proportion Analysis by Market Taxonomy

        15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.6.2.1. By Nutrient Type

    15.7. France Parenteral Nutrition Market Analysis

        15.7.1. Value Proportion Analysis by Market Taxonomy

        15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.7.2.1. By Nutrient Type

    15.8. Italy Parenteral Nutrition Market Analysis

        15.8.1. Value Proportion Analysis by Market Taxonomy

        15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.8.2.1. By Nutrient Type

    15.9. BENELUX Parenteral Nutrition Market Analysis

        15.9.1. Value Proportion Analysis by Market Taxonomy

        15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.9.2.1. By Nutrient Type

    15.10. UK Parenteral Nutrition Market Analysis

        15.10.1. Value Proportion Analysis by Market Taxonomy

        15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.10.2.1. By Nutrient Type

    15.11. Nordic Countries Parenteral Nutrition Market Analysis

        15.11.1. Value Proportion Analysis by Market Taxonomy

        15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.11.2.1. By Nutrient Type

    15.12. China Parenteral Nutrition Market Analysis

        15.12.1. Value Proportion Analysis by Market Taxonomy

        15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.12.2.1. By Nutrient Type

    15.13. Japan Parenteral Nutrition Market Analysis

        15.13.1. Value Proportion Analysis by Market Taxonomy

        15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.13.2.1. By Nutrient Type

    15.14. South Korea Parenteral Nutrition Market Analysis

        15.14.1. Value Proportion Analysis by Market Taxonomy

        15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.14.2.1. By Nutrient Type

    15.15. GCC Countries Parenteral Nutrition Market Analysis

        15.15.1. Value Proportion Analysis by Market Taxonomy

        15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.15.2.1. By Nutrient Type

    15.16. South Africa Parenteral Nutrition Market Analysis

        15.16.1. Value Proportion Analysis by Market Taxonomy

        15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.16.2.1. By Nutrient Type

    15.17. Turkey Parenteral Nutrition Market Analysis

        15.17.1. Value Proportion Analysis by Market Taxonomy

        15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.17.2.1. By Nutrient Type

        15.17.3. Competition Landscape and Player Concentration in the Country

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies 

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

        16.4.1. By Regional footprint of Players

        16.4.2. Product footprint by Players

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive 

        17.3.1. B. BRAUN MELSUNGEN AG

            17.3.1.1. Overview

            17.3.1.2. Product Portfolio

            17.3.1.3. Sales Footprint

            17.3.1.4. Strategy Overview

        17.3.2. FRESENIUS KABI AG

            17.3.2.1. Overview

            17.3.2.2. Product Portfolio

            17.3.2.3. Sales Footprint

            17.3.2.4. Strategy Overview

        17.3.3. ALLERGAN

            17.3.3.1. Overview

            17.3.3.2. Product Portfolio

            17.3.3.3. Sales Footprint

            17.3.3.4. Strategy Overview

        17.3.4. GRIFOLS, S.A.

            17.3.4.1. Overview

            17.3.4.2. Product Portfolio

            17.3.4.3. Sales Footprint

            17.3.4.4. Strategy Overview

        17.3.5. PFIZER, INC.(HOSPIRA)

            17.3.5.1. Overview

            17.3.5.2. Product Portfolio

            17.3.5.3. Sales Footprint

            17.3.5.4. Strategy Overview

        17.3.6. OTSUKA PHARMACEUTICAL FACTORY, INC.

            17.3.6.1. Overview

            17.3.6.2. Product Portfolio

            17.3.6.3. Sales Footprint

            17.3.6.4. Strategy Overview

        17.3.7. BAXTER

            17.3.7.1. Overview

            17.3.7.2. Product Portfolio

            17.3.7.3. Sales Footprint

            17.3.7.4. Strategy Overview

        17.3.8. ACULIFE (NIRLIFE)

            17.3.8.1. Overview

            17.3.8.2. Product Portfolio

            17.3.8.3. Sales Footprint

            17.3.8.4. Strategy Overview

        17.3.9. SICHUAN KELUN PHARMACEUTICAL CO., LTD

            17.3.9.1. Overview

            17.3.9.2. Product Portfolio

            17.3.9.3. Sales Footprint

            17.3.9.4. Strategy Overview

        17.3.10. VIFOR PHARMA

            17.3.10.1. Overview

            17.3.10.2. Product Portfolio

            17.3.10.3. Sales Footprint

            17.3.10.4. Strategy Overview

18. Assumptions and Acronyms Used

19. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 1: Global Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2015 – 2021

Table 2: Global Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2022 – 2032

Table 3: Global Parenteral Nutrition Market, By Region, 2015 – 2021

Table 4: Global Parenteral Nutrition Market, By Region, 2022 – 2032

Table 5: North America Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2015 – 2021

Table 6: North America Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2022 – 2032

Table 7: North America Parenteral Nutrition Market, By Country, 2015 – 2021

Table 8: North America Parenteral Nutrition Market, By Country, 2022 – 2032

Table 9: Latin America Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2015 – 2021

Table 10: Latin America Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2022 – 2032

Table 11: Latin America Parenteral Nutrition Market, By Country, 2015 – 2021

Table 12: Latin America Parenteral Nutrition Market, By Country, 2022 – 2032

Table 13: Europe Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2015 – 2021

Table 14: Europe Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2022 – 2032

Table 15: Europe Parenteral Nutrition Market, By Country, 2015 – 2021

Table 16: Europe Parenteral Nutrition Market, By Country, 2022 – 2032

Table 17: Asia Pacific Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2015 – 2021

Table 18: Asia Pacific Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2022 – 2032

Table 19: Asia Pacific Parenteral Nutrition Market, By Country, 2015 – 2021

Table 20: Asia Pacific Parenteral Nutrition Market, By Country, 2022 – 2032

Table 21: MEA Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2015 – 2021

Table 22: MEA Parenteral Nutrition Market Value (US$ Mn), By Nutrient Type, 2022 – 2032

Table 23: MEA Parenteral Nutrition Market, By Country, 2015 – 2021

Table 24: MEA Parenteral Nutrition Market, By Country, 2022 – 2032

Table 25: Global Parenteral Nutrition Market Incremental $ Opportunity, By Nutrient Type, 2015 - 2021

Table 26: Global Parenteral Nutrition Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 27: North America Parenteral Nutrition Market Incremental $ Opportunity, By Nutrient Type, 2015 - 2021

Table 28: North America Parenteral Nutrition Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 29: Latin America Parenteral Nutrition Market Incremental $ Opportunity, By Nutrient Type, 2015 - 2021

Table 30: Latin America Parenteral Nutrition Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 31: Europe Parenteral Nutrition Market Incremental $ Opportunity, By Nutrient Type, 2015 - 2021

Table 32: Europe Parenteral Nutrition Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 33: Asia Pacific Parenteral Nutrition Market Incremental $ Opportunity, By Nutrient Type, 2015 - 2021

Table 34: Asia Pacific Parenteral Nutrition Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 35: MEA Parenteral Nutrition Market Incremental $ Opportunity, By Nutrient Type, 2015 - 2021

Table 36: MEA Parenteral Nutrition Market Incremental $ Opportunity, By Country, 2022 - 2032

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 1: Global Parenteral Nutrition Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Parenteral Nutrition Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Parenteral Nutrition Market Share, By Nutrient Type, 2022 & 2032

Figure 4: Global Parenteral Nutrition Market Y-o-Y Growth Projections, By Nutrient Type – 2022-2032

Figure 5: Global Parenteral Nutrition Market Attractiveness Index, By Nutrient Type – 2022-2032

Figure 6: Global Parenteral Nutrition Market Share, By Region, 2022 & 2032

Figure 7: Global Parenteral Nutrition Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 8: Global Parenteral Nutrition Market Attractiveness Index, By Region – 2022-2032

Figure 9: North America Parenteral Nutrition Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 10: North America Parenteral Nutrition Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 11: North America Parenteral Nutrition Market Share, By Nutrient Type, 2022 & 2032

Figure 12: North America Parenteral Nutrition Market Y-o-Y Growth Projections, By Nutrient Type – 2022-2032

Figure 13: North America Parenteral Nutrition Market Attractiveness Index, By Nutrient Type – 2022-2032

Figure 14: North America Parenteral Nutrition Market Share, By Country, 2022 & 2032

Figure 15: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 16: North America Market Attractiveness Index, By Country – 2022-2032

Figure 17: Latin America Parenteral Nutrition Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 18: Latin America Parenteral Nutrition Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 19: Latin America Parenteral Nutrition Market Share, By Nutrient Type, 2022 & 2032

Figure 20: Latin America Parenteral Nutrition Market Y-o-Y Growth Projections, By Nutrient Type – 2022-2032

Figure 21: Latin America Parenteral Nutrition Market Attractiveness Index, By Nutrient Type – 2022-2032

Figure 22: Latin America Parenteral Nutrition Market Share, By Country, 2022 & 2032

Figure 23: Latin America Parenteral Nutrition Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 24: Latin America Parenteral Nutrition Market Attractiveness Index, By Country – 2022-2032

Figure 25: Europe Parenteral Nutrition Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 26: Europe Parenteral Nutrition Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 27: Europe Parenteral Nutrition Market Share, By Nutrient Type, 2022 & 2032

Figure 28: Europe Parenteral Nutrition Market Y-o-Y Growth Projections, By Nutrient Type – 2022-2032

Figure 29: Europe Parenteral Nutrition Market Attractiveness Index, By Nutrient Type – 2022-2032

Figure 30: Europe Parenteral Nutrition Market Share, By Country, 2022 & 2032

Figure 31: Europe Parenteral Nutrition Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 32: Europe Parenteral Nutrition Market Attractiveness Index, By Country – 2022-2032

Figure 33: MEA Parenteral Nutrition Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 34: MEA Parenteral Nutrition Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 35: MEA Parenteral Nutrition Market Share, By Nutrient Type, 2022 & 2032

Figure 36: MEA Parenteral Nutrition Market Y-o-Y Growth Projections, By Nutrient Type – 2022-2032

Figure 37: MEA Parenteral Nutrition Market Attractiveness Index, By Nutrient Type – 2022-2032

Figure 38: MEA Parenteral Nutrition Market Share, By Country, 2022 & 2032

Figure 39: MEA Parenteral Nutrition Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 40: MEA Parenteral Nutrition Market Attractiveness Index, By Country – 2022-2032

Figure 41: Asia Pacific Parenteral Nutrition Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 42: Asia Pacific Parenteral Nutrition Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 43: Asia Pacific Parenteral Nutrition Market Share, By Nutrient Type, 2022 & 2032

Figure 44: Asia Pacific Parenteral Nutrition Market Y-o-Y Growth Projections, By Nutrient Type – 2022-2032

Figure 45: Asia Pacific Parenteral Nutrition Market Attractiveness Index, By Nutrient Type – 2022-2032

Figure 46: Asia Pacific Parenteral Nutrition Market Share, By Country, 2022 & 2032

Figure 47: Asia Pacific Parenteral Nutrition Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 48: Asia Pacific Parenteral Nutrition Market Attractiveness Index, By Country – 2022-2032

Figure 49: US Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 50: US Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 51: Canada Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 52: Canada Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 53: Brazil Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 54: Brazil Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 55: Mexico Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 56: Mexico Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 57: Germany Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 58: Germany Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 59: U.K. Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 60: U.K. Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 61: France Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 62: France Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 63: Italy Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 64: Italy Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 65: BENELUX Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 66: BENELUX Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 67: Nordic Countries Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 68: Nordic Countries Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 69: China Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 70: China Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 71: Japan Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 72: Japan Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 73: South Korea Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 74: South Korea Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 75: GCC Countries Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 76: GCC Countries Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 77: South Africa Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 78: South Africa Parenteral Nutrition Market Share, By Nutrient Type, 2021

Figure 79: Turkey Parenteral Nutrition Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 80: Turkey Parenteral Nutrition Market Share, By Nutrient Type, 2021

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What is the projected growth rate of the market for parenteral nutrition products from 2022 to 2032?

From 2022-2032, parenteral nutrition product sales are expected to surge at a CAGR of 7%

As per the report, what is the projected market value for parenteral nutrition products in 2032?

By 2032, the market for parenteral nutrition products is likely to reach US$ 14 Billion

What is the growth outlook for the market for parenteral nutrition in North America?

North America is expected to generate 42% of the global parenteral nutrition market revenue

How opportunistic will the market likely be in the Asia-Pacific?

According to Fact.MR, parenteral nutrition products sales will likely incline at a CAGR of 8% from 2022 to 2032

What is the expected contribution of single dose amino acid parenteral nutrition products?

Single does parenteral nutrition products are forecast to yield 31% of the global market revenue

By how much are parenteral lipid emulsions expected to grow until 2032?

Parenteral lipid emulsions sales are expected to surge at a CAGR of 7%

What is the anticipated market value for parenteral nutrition in 2022?

By 2022-end, Fact.MR expects the parenteral nutrition market to reach US$ 7 Bn

At what CAGR did parenteral nutrition product sales surge from 2015 to 2021?

From 2015 to 2021, parenteral nutrition products demand surged at a CAGR of 6.4%

At what value did the market for parenteral nutrition close in 2021?

As of 2021, the market for parenteral nutrition was valued at US$ 6 Billion, as per Fact.MR

Parenteral Nutrition Market

Schedule a Call